Navigation Links
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
Date:5/12/2008

o the market, Intercell is fully committed to becoming the leading pure play vaccine company globally. We look forward to welcoming Iomai's employees to Intercell and are excited by the potential of the combined group to create significant value for all stakeholders."

Stanley C. Erck, President and CEO of Iomai, said: "We have built a dynamic and scientifically driven organisation. This strategic combination with Intercell will create a stronger, more diversified vaccine company and will accelerate the development of Iomai's vaccine programs and fully leverage our innovative TCI technology. We believe this transaction is in the best interest of all parties, including shareholders, employees and ultimately patients."

Intercell will also gain full rights to two additional clinical and three preclinical programs under development, the most advanced being an immunostimulant vaccine patch in Phase II for pandemic influenza. This patch is designed to enhance the immune response compared to injected pandemic influenza vaccines. If successful, it would have the effect of expanding limited vaccine supplies by allowing public health officials to use fewer or lower doses of the vaccine. The vaccine patch has recently generated positive interim immunogenicity data in a 500-subject Phase I/II study with a one-dose application. The program is funded by a grant from the United States Department of Health and Human Services.

Iomai's pioneering work in transcutaneous immunization (TCI) technology has led to the development of a simple and promising needle-free vaccine patch. This highly innovative vaccine delivery system provides a potential future alternative to current injected vaccines. TCI technology has the potential to enhance the efficacy of existing vaccines, replace current vaccines that have a cumbersome mode of administration and enable the development of new vaccines that are not viable to be delivered via an injection.

Iomai's TCI technology
'/>"/>

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
3. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. U.S. Preventive Medicine Acquires Specialty Disease Management
6. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
7. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
11. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 21, 2015 Research and Markets ( ... "Pharmaceutical Industry in China to 2020: An ... Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, ... This report tackles not only ... but also home grown companies and ...
(Date:7/28/2015)... 28, 2015  Alere Inc. (NYSE: ALR ), ... it will release its financial results for the second ... a conference call beginning at 8:30 a.m. ET on ... provide business updates. The conference call ... of Alere,s website, or accessed directly through the following ...
(Date:7/28/2015)... VANCOUVER and HOUSTON, TX , ... "Company") (NASDAQ: EPIX ) is pleased to announce that ... be listed and commence trading on the Toronto Stock Exchange ... the opening of trading on Tuesday, July 28, 2015 under ... delisted from the TSX Venture Exchange. About ...
Breaking Medicine Technology:Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Alere to Report Second Quarter 2015 Financial Results on August 4, 2015 2ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 2ESSA Pharma Inc. to Commence Trading on the Toronto Stock Exchange 3
... 2010 General-use X-ray security systems are one ... to widespread use to check people entering secured ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... the low risk to health associated with these ...
... N.Y., Nov. 4, 2010 At a special meeting today, ... approve the merger of West Acquisition Corp., an indirect wholly ... ), with and into Penwest and voted to approve the ... Penwest, West and Endo.   The merger became ...
Cached Medicine Technology:
(Date:7/28/2015)... ... July 28, 2015 , ... Healthpointe ’s Cosmetic ... returns skin to a smooth state, and reduces the appearance of fine lines and ... only FDA-approved injectable gel to instantly add volume to your cheek area to correct ...
(Date:7/28/2015)... ... ... According to WFTV on July 15th heroin overdose rates have increased by ... recent statistic Orlando suffers at least one death weekly as a direct result of ... enforcement officials are struggling to keep apace with its distribution. Officers rely on inside ...
(Date:7/28/2015)... Arkansas (PRWEB) , ... July 28, 2015 , ... ... company developing targeted biologics and biologic-device combination products for the treatment of bone ... Office issued U.S. Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and ...
(Date:7/28/2015)... ... July 28, 2015 , ... Women fear developing Alzheimer's disease ... that cancer, heart attack, and stroke are treatable, but there is little an individual ... is to take part in a clinical trial, reports the July 2015 Harvard ...
(Date:7/28/2015)... ... July 28, 2015 , ... A June 3, 2015 ... Stenosis Injury" discussed baseball player David Wright’s spinal stenosis injury and his chances ... on by degenerative changes in the spine, rather than congenital, which is good ...
Breaking Medicine News(10 mins):Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 2Health News:Heroin Overdose Deaths Increase by 270 Percent, Orlando Takes the Lead 3Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 2Health News:Spine Surgeon Weighs in on Uncertain Future Baseball Career Future for David Wright 3
... in Boston suggests that daily use of inhaled steroids may ... ,Dr. Gregory Sawicki insists that a study ... that over a period of one-year, children who used inhaled ... having well-controlled asthma in comparison to non-users of steroids. ...
... Nottingham experts have joined forces with Canadian biotech company ... the fight against food poisoning . ,They ... methods for the control of Campylobacter the commonest ... Wales, according to the Health Protection Agency. Campylobacters are ...
... University of Warwick have found that sexual orientation has a ... navigating with a map in a car but that ... and withers all mens minds alike just ahead of womens. ... BBC to collect data from over 198,000 people aged 2065 ...
... that women who regularly enjoy an alcoholic drink or two ... heart attack than women who are life-time abstainers. ,Women ... a month were nearly three times more likely to suffer ... ,One difference in the protective pattern among drinkers involved those ...
... science could employ aspirin and new aspirin-like drugs for ... ,The study was conducted by a ... Ireland Cancer Center. ,As part of the ... use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), also ...
... improvements in the ability to diagnose malaria, these ... patients with negative test results are often prescribed ... ,The recent introduction of the effective but ... for malaria throughout Africa has led to renewed ...
Cached Medicine News:Health News:Use of Inhaled Steroids on Daily Basis may Not Control Childhood Asthma 2Health News:Experts to Develop New Weapons Against Food Poisoning 2Health News:Experts to Develop New Weapons Against Food Poisoning 3Health News:A Tipple a Day may Be heart Friendly for Women 2Health News:Aspirin may Help to Prevent Colon Cancer in High-risk Individuals 2Health News:Diagnostic Tests for Malaria Underused in Zambia 2
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
... Central platform with integrated neck. ... platform utilizing an internal spring to ... use. Cutting Block fits into precision ... trephine blades sized 6.25 - 9.0mm. ...
Adjustable piston accommodates 7-9mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9mm trephine blades and 18mm diameter Teflon block. Designed for accurate donor...
Medicine Products: